http://www.unboundmedicine.com/medline/ebm/research/pimecrolimusUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19889396/full_citation/The_effect_of_topical_pimecrolimus_on_inflammatory_infiltrate_in_vulvar_lichen_sclerosus_Kauppila S, Kotila V, Knuuti E, et al. 
The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus. [JOURNAL ARTICLE]
Am J Obstet Gynecol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877726/full_citation/Topical_pimecrolimus:_a_review_of_its_use_in_the_management_of_pediatric_atopic_dermatitis_Yang LP, Curran MP 
Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis. [Journal Article]
Paediatr Drugs 2009; 11(6):407-26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19874342/full_citation/What's_new_in_atopic_eczema_An_analysis_of_systematic_reviews_published_in_2007_and_2008__Part_2__Disease_prevention_and_treatment_Williams HC, Grindlay DJ 
What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment. [JOURNAL ARTICLE]
Clin Exp Dermatol 2009 Oct 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19850265/full_citation/Do_we_really_understand_pimecrolimusVorpahl M, Finn AV, Nakano M, et al. 
Do we really understand pimecrolimus? [Editorial]
JACC Cardiovasc Interv 2009 Oct; 2(10):1025-7.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19850264/full_citation/Feasibility_safety_and_efficacy_of_a_novel_polymeric_pimecrolimus_eluting_stent_traditional_pre_clinical_safety_end_points_failed_to_predict_6_month_clinical_angiographic_results_Ormiston JA, Webster MW, Schwartz RS, et al. 
Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results. [Journal Article]
JACC Cardiovasc Interv 2009 Oct; 2(10):1017-24.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19840309/full_citation/Twice_daily_versus_Once_daily_Applications_of_Pimecrolimus_Cream_1_for_the_Prevention_of_Disease_Relapse_in_Pediatric_Patients_with_Atopic_Dermatitis_Ruer-Mulard M, Aberer W, Gunstone A, et al. 
Twice-daily versus Once-daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis. [Journal Article]
Pediatr Dermatol 2009 Sep-Oct; 26(5):551-8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19836643/full_citation/Calcineurin_inhibitors_in_oral_medicine_Al Johani KA, Hegarty AM, Porter SR, et al. 
Calcineurin inhibitors in oral medicine. [Journal Article, Research Support, Non-U.S. Gov't]
J Am Acad Dermatol 2009 Nov; 61(5):829-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19832287/full_citation/A_case_of_herpes_zoster_during_pimecrolimus_use_for_the_treatment_of_subacute_cutaneous_lupus_erythematosus_Tatlican S, Eren C, Atacan D, et al. 
A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus. [JOURNAL ARTICLE]
J Dermatolog Treat 2009 Oct 16.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821298/full_citation/Drugs_for_discoid_lupus_erythematosus_Jessop S, Whitelaw DA, Delamere FM 
Drugs for discoid lupus erythematosus. [Journal Article]
Cochrane Database Syst Rev 2009; (4):CD002954.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19798455/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Jul-Aug; 31(6):397-417.
Abstract | Full Citation